Target intelligence / Profile preview

Reactive oxygen species and electrophilic intermediates (ROS and electrophilic intermediates)

Target
ROS and electrophilic intermediates
Molecular classification
Other
01

Overview

Reactive oxygen species (ROS) are a collective term for highly reactive, oxygen-containing molecules such as superoxide, hydrogen peroxide, hydroxyl radical, and singlet oxygen, among others[1][2][4][5]. ROS are generated as by-products of normal cellular metabolism, particularly in mitochondria, and are also produced in response to stress, xenobiotics, cytokines, and immune activation[4][2]. Electrophilic intermediates refer to electron-deficient species (such as α,β-unsaturated aldehydes and certain lipid oxidation products) generated as secondary products from ROS reactions with biomolecules or by xenobiotic metabolism[1][3]. Both ROS and electrophilic intermediates can cause cellular damage through oxidation of DNA, proteins, and lipids, but in lower concentrations, they play crucial roles as signaling molecules for cell proliferation, survival, and stress responses[4][5]. Excessive or uncontrolled levels drive pathological processes implicated in many diseases, including cancer, neurodegeneration, cardiovascular and inflammatory diseases, and aging[1][4]. Although numerous drugs and antioxidants modulate ROS/electrophile pathways, these entities are not conventional molecular drug targets—rather, they represent a chemical class and redox process, not a defined receptor, enzyme, or transporter[1][4][5]. Note: - This entry does not refer to a single, defined molecular target (like a receptor or enzyme) but rather to a broad chemical category. Thus, it is not a "therapeutic target" in the strict sense, and this designation is incorrect for a molecular target database[1][2][4]. - If you intend to refer to a specific enzyme or protein that generates, detoxifies, or senses ROS/electrophiles (such as NADPH oxidase, superoxide dismutase, or the Nrf2 pathway), refer to that specific protein by its accepted gene or protein name.

Other names
ROS and electrophilesReactive oxygen intermediatesReactive oxygen metabolitesOxygen radicals
02

Mechanism of action

Scavenging of reactive oxygen species; Inhibition of ROS formation; Induction of ROS to trigger cell death (pro-oxidant anticancer drugs); Modulation of redox-sensitive signaling pathways

03

Biological functions

Cell signalingCell proliferationCell deathOxidative stress responseDamage to biomoleculesImmune response
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseAgingInfection
05

Safety considerations

Lack of specificity in drug targeting (ROS/electrophiles are not single molecular entities)Risk of interfering with physiological signaling functionsPotential for off-target effects and toxicity, especially with antioxidant therapy and ROS-inducing agents
06

Interacting drugs

Antioxidants (e.g., N-acetylcysteine, vitamin C, vitamin E)

3 more in the full profile.

07

Biomarkers

8-oxo-dG (8-oxo-2'-deoxyguanosine)Malondialdehyde (MDA)Protein carbonyl contentF2-isoprostanes

Beyond the preview

Go deeper on Reactive oxygen species and electrophilic intermediates (ROS and electrophilic intermediates).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and electrophilic intermediates (ROS and electrophilic intermediates).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call